91344-89-7 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 4-oxo-3,4-dihydro-2H-chromene-8-carboxylate is used as an intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a versatile building block for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
As a member of the coumarin family, Methyl 4-oxo-3,4-dihydro-2H-chromene-8-carboxylate may also find applications in the agrochemical industry. Its potential use in the development of new agrochemical products could contribute to advancements in crop protection and pest management.
Used as a Flavoring Agent:
Due to its aromatic nature, Methyl 4-oxo-3,4-dihydro-2H-chromene-8-carboxylate may be used as a flavoring agent in the food and beverage industry. Its unique scent and taste profile could be utilized to enhance the sensory experience of various products.
Used as a Fragrance Ingredient:
Similarly, Methyl 4-oxo-3,4-dihydro-2H-chroMene-8-carboxylate may also be employed as a fragrance ingredient in the cosmetics and perfumery industry. Its aromatic properties could contribute to the creation of novel and appealing scents for a wide range of products.
Check Digit Verification of cas no
The CAS Registry Mumber 91344-89-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,3,4 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 91344-89:
(7*9)+(6*1)+(5*3)+(4*4)+(3*4)+(2*8)+(1*9)=137
137 % 10 = 7
So 91344-89-7 is a valid CAS Registry Number.
91344-89-7Relevant academic research and scientific papers
SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME
-
Page/Page column 66; 68; 69, (2018/04/14)
The present invention includes novel substituted bicyclic (such as 4-substituted-chromane-8-carboxamide compounds), and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention are capsid inhibitors.
